Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apollo Hospitals EnterpriseBOM:508869 +0.37%93 Pretax Margin % is 10.92% as of Mar. 2026, which is 70% above its 10-year median of 6.44. GuruFocus rates BOM:508869 with a GF Score™ of 93/100 and a GF Value™ of ₹8,783.58 (Fairly Valued). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Apollo Hospitals Enterprise ranks better than 72.78% on this metric.
The historical rank and industry rank for Apollo Hospitals Enterprise's Pretax Margin % or its related term are showing as below:
BOM:508869'
s Pretax Margin % Range Over the Past 10 Years
Min: 2.09 Med: 6.44 Max: 10.86
Current: 10.55
BOM:508869's Pretax Margin % is ranked better than 72.78% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs BOM:508869: 10.55
Apollo Hospitals Enterprise (BOM:508869) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Apollo Hospitals Enterprise Pretax Margin % Related Terms
Apollo Hospitals Enterprise Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:508869 vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apollo Hospitals Enterprise Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Apollo Hospitals Enterprise's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise (BOM:508869) has a Pretax Margin % of 10.92% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Apollo Hospitals Enterprise and its competitors. This is 70% above median its historical median of 6.44. Over the past decade, Apollo Hospitals Enterprise's Pretax Margin % has ranged from 2.09 to 10.86. According to the industry distribution chart, Apollo Hospitals Enterprise ranks #181 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 27.2%.
Is Apollo Hospitals Enterprise's Pretax Margin % too high?
Apollo Hospitals Enterprise's current Pretax Margin % of 10.92% is 70% above median its 10-year median of 6.44. Over the past 10 years, this metric has ranged from a low of 2.09 to a high of 10.86. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. Apollo Hospitals Enterprise's value of 10.92% is 171.6% above this industry median. Based on the distribution chart, Apollo Hospitals Enterprise ranks #181 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apollo Hospitals Enterprise has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Apollo Hospitals Enterprise ranks #181 out of 665 companies for Pretax Margin %. This puts Apollo Hospitals Enterprise in the upper half of its industry. The industry median Pretax Margin % is 4.02. Apollo Hospitals Enterprise's value of 10.92% is 171.6% above this benchmark. Historically, Apollo Hospitals Enterprise's own Pretax Margin % has ranged from 2.09 to 10.86 over the past decade. While the company's 10-year median is 6.44 vs. the industry median of 4.02, Apollo Hospitals Enterprise has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current Pretax Margin % of 10.92% is 171.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Apollo Hospitals Enterprise and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current Pretax Margin % is 10.92%, which is 70% above median its own 10-year median of 6.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,783.58, compared to a current price of ₹8,933.85 — trading 1.7% above its estimated fair value. The current Pretax Margin % is 10.92%, which is 70% above median its 10-year median of 6.44 and 171.6% above the Healthcare Providers & Services industry median of 4.02. Apollo Hospitals Enterprise's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Pretax Margin % is 10.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be overvalued.
The current stock price of ₹8,933.85 is trading 1.7% above its estimated GF Value™ of ₹8,783.58.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
Pretax Margin %: 10.92% (70% above median its 10-year median of 6.44)
GF Value™: ₹8,783.58 vs. price of ₹8,933.85 (1.7% above fair value)
Industry Position: 171.6% above the Healthcare Providers & Services median (#181 of 665)
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
93GF Score
Get the complete analysis for BOM:508869
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
